INTRODUCTION
The major difference between home care of adult and paediatric patients is the shift of responsibility for treatment. In the paediatric setting it is largely the parent who is responsible for treatment. In the adult clinic the young adult is encouraged to take over responsibility for their treatment in order to become self caring. This change in emphasis of care coincides with the problems of adolescence. This may be accompanied by resentment. Illness may be used as a weaponl. There may be behaviour problems. The adolescent needs time to explore their feelings and needs support from the cystic fibrosis (CF) team to adapt to becoming an adult with CF and the problems that can pose for them.
The transfer from paediatric to adult care can be perceived as a difficult experience by the family required to change their centre of care. Excellent communication is required between the paediatric and adult clinic to effect a smooth transition in all aspects of care including the continuation of established home intravenous (i.v.) treatment. I will discuss the problems and practical issues of adult home care based on our experience at the adult CF unit in Manchester.
ASSOCIATED PROBLEM AREAS

Education
The adult patient often needs complete re-education about their illness. Parental management of the illness may have excluded active participation by the young person who now has to learn more about their condition in order to understand the need for certain aspects of their treatment.
Patients may feel that they do not require education. The process has to be gradual and on going. It is important not to undermine their confidence but to build on their existing knowledge.
State of health
As the patient becomes older the severity of the disease increases. The adult may have moved away from the family home to attain independence. They may be in a situation of having deteriorating health combined with less support at home. Admission during i.v. treatment may not be possible due to a shortage of beds. We need to balance the use of home i.v. treatment with that of hospital treatment to optimize benefit to the patient.
Adherence
The issues of adherence have been well documented2'3. The methodological difficulties in trying to identify estimates of adherence were discussed by D'Angelo 19964. Adherence being best for aspects of treatment that have immediate consequences when not completed and worst for components intruding on daily life or which cause unpleasant side effects.
Adherence can be improved by assessing the patient's knowledge of the regimen. Proper implementation can be achieved by simplifying and tailoring the regimen to fit the individual's life circumstances. This needs to be taken into consideration when prescribing treatment.
THE ROLE OF THE NURSE SPECIALIST FOR ADULTS RECEIVING INTRAVENOUS ANTIBIOTICS
AT HOME Re-starting the education process As the young adult transfers from the paediatric unit their knowledge of their illness and treatment needs to be assessed. A teaching programme tailored to each individual's needs is required. This includes one to one explanations, the provision of written materials and identifying suitable visual aids for those with literacy problems and other disabilities, e.g. deafness.
Supervision at home
The extent of supervision at home will depend on the individual patient, his/her needs and previous experiences of successfully carrying out home i.v. treatment. The CF nurse specialist will set the standard for the home care service along with his/her colleagues in the multidisciplinary team. These will vary between individual units. The clinical guidelines for CF care5 recommends that standards of home care must be as good as those in hospital, however, it fails to address the resource implications of this statement.
We find that many of our patients require only telephone contact to address any concerns, whereas other patients require regular home visits. We arrange follow up outpatient appointments at one week and at the end of treatment to assess progress.
The extent of monitoring at home will depend on each unit's policy. Spirometry can be carried out at home as can venepuncture and cannulation.
Venous access
The nurse is usually responsible for the care of venous access devices. We prefer to use peripherally inserted mid line catheters for home i.v. treatment. However, some of our patients still prefer to use venflons.
As repeated courses of intravenous antibiotics are carried out it can be increasingly difficult to secure reliable venous access. In these situations a totally implantable venous access device (TIVAD) is suggested to the patient. In our unit the nurse discusses with the patient the most suitable device. The patient is taught how to care for the device correctly. Maintenance of the device, i.e. needle insertion, monthly flushes is carried out by the CF nurse specialist, ward staff, practice nurse, GP, a carer or the patient themselves. The CF nurse specialist carries out training for those to be involved in caring for these devices.
Community staff
The CF nurse specialist liaises with community staff to establish additional support for the patient. Education of community staff in relation to home i.v. revolves around care of a TIVAD or educating district nurses to prepare and administer i.v. antibiotics to relieve patients and/or their carers of the burden.
Quality of service
The CF nurse specialist also plays a role in improving the quality of service offered to the patient through staff education and the provision of suitable teaching materials. Discussing the patients' needs identifies any potential problems and enables provisions to be made to minimize their effect. The nurse provides a link between the hospital and home and acts as a point of contact.
COMMENCING TREATMENT-PRACTICAL DETAILS
Good patient selection is extremely important68. Compliance with other forms of treatment being evident. The suitability of the patient to carry out home i.v. treatment should have been discussed within the CF team. Potential problems should have been identified prior to commencing situations need to be continually re-assessed. It may no longer be feasible for a patient who has previously carried out home i.v. treatment to continue to do so, because of changing home circumstances or deteriorating health. Patients do not always recognize their declining health9 and may need a period of re-adjustment. Conversely patients previously felt to be unsuitable for home treatment may now be eligible to carry out this form of treatment.
Patients who have not previously carried out home i.v. treatment should be admitted for a period of assessment to ensure adequate education and supervision has taken place. The time required for this will vary with each individual.
Home commitments need to be assessed and a drug regimen selected to fit around these and other treatment schedules. There is much discussion at the moment as to which methods and timings of administration have the greatest pharmacokinetic effect. This needs to be balanced with the patient's ability to administer the drug as prescribed. If the demands are unreasonable then the patient will fail to adhere to the treatment and optimal benefit will still not be achieved. One of the advantages of home i.v. treatment is the perceived improvement in quality of life for the patient. Tullisl0 in a study of quality of life in adults with CF identified the ongoing struggle between balancing everyday activities with treatment demands and we need to ensure that we do not overwhelm the patient reducing their quality of life.
First doses of antibiotics are given in the outpatient clinic to observe for any adverse reactions. Patients are informed of any potential adverse reactions and given advice on how to deal with them should they occur. Epi-pens are not routinely given to our patients but are supplied to those with a strong history of allergies. In some cases the first dose may be given in the patient's home by the CF nurse and drugs are carried to deal with anaphylaxis.
The monitoring of drug levels can be carried out in the CF centre, in the patient's home by the CF nurse, by the patient's GP, or local hospital dependent upon patient preference and convenience.
It is also important to identify where the patient should go in case of difficulties with their venous access device. Many patients prefer to return to the CF centre. However, for some patients this is impractical and they can go to their local Accident and Emergency department or in some cases their GP for a replacement line. A letter may be required for the patient to take with them should the need arise.
STUDIES ON HOME I.V. TREATMENT The benefits of home i.v. treatment and the need for careful patient selection have been well documented68. Some excellent studies have also been carried out to evaluate the effects of home i.v. treatment1 1-13 compared with hospital treatment so that contingency plans can be made. Patients ) treatment. Donati carried out the only prospective controlled study. The studies have all been short term and evaluate clinical response. The conclusions being that home i.v. treatment is equally effective given proper patient selection and adequate patient monitoring. The studies fail to address issues of compliance.
Our experience suggests that our patients improve clinically as a result of home i.v. treatment. However, in view of the practical difficulties outlined above we decided to try and identify the problems our patients experienced and to audit the service being provided.
A study was carried out to identify problem areas and improve the service offered with continuing education and to provide baseline information to enable audit of the systeml4 (see Table 1 ).
Undoubtedly there are benefits of home i.v. treatment for patients but it is important that we identify the potential problems and provide continuing education and audit the service we are providing. Despite the problems that were identified, the majority of our patients felt the advantages outweighed the disadvantages and felt confident about home i.v. treatment. We are still keen to allow patients to carry out home i.v. treatment, in view of the perceived improvement in their quality of life, but feel that continuing audit of the service particularly in view of its expense will be required to satisfy the purchasers in the future. 
